Reporter brief
Evaluating the Safety and Efficacy of Injectable Combination Klotho and Follistatin Plasmid Gene Therapy in Humans -- An Interventional, Non-Placebo Controlled Pilot Phase Study
What happened
Trial registry update: COMPLETED. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Lack of placebo control means any reported benefits cannot be distinguished from placebo response or natural variation. The abstract does not report actual results, sample size, or effect sizes, preventing assessment of what was actually found. Pilot phase design with small uncontrolled groups cannot establish efficacy or safety for broader clinical use.
Study design and sample
Observational; Human.
healthy adult volunteers
- Design
- Observational
- Sample
- —
- Journal
- Minicircle
- Published
- Aug 27, 2026
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Klotho timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.